Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2006

Sep 6, 2006

30339_dirs_2006-09-06_17211d95-a7bb-4be0-b030-9e38c6576a30.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: WEST PHARMACEUTICAL SERVICES INC (wst)
CIK: 0000105770
Period of Report: 2005-03-07

Reporting Person: HARGESHEIMER ROBERT S (President - The Tech Group)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-03-07 Common Stock A 2731.598 Acquired 21482.4402 Direct
2006-02-24 Common Stock A 3928.168 Acquired 24997.6512 Direct

Footnotes

F1: Settlement for stock of Performance Rights that are non-derivative securities. See explanation below for further information.

F2: The Reporting Person was awarded 2,260 Performance Vesting Restricted (PVR) Shares on May 5, 2004 and 4,340 PVR Shares on June 29, 2004 for a total of 6,600 PVR Shares following the Company's 2004 stock split. The 2004 PVR Share Awards were inappropriately reported as restricted stock awards. In fact, the 2004 PVR Share Awards constituted performance rights that are non-derivative securities. As such, no reports should have been filed until the PVR Awards are settled in stock. Reporting the initial grant resulted in an overstatement of the amount of securities beneficially owned (Column 5, Table 1) in subsequently filed reports. The Reporting Person is filing this report to: (i) properly characterize the PVR Shares as performance rights; and (ii) adjust the amount of securities beneficially owned and eliminate the overstatement.

F3: Amount as of filing date.